Search
Menu
Home
Sources
About
Contacts
Sabcomeline
Sabcomeline
is a
selective
M
1
receptor
partial agonist
that was
under development
for the
treatment
of
Alzheimer's disease
. It made it to
phase III
clinical trials
before being discontinued due to
poor
results
.